See also this year's filing and all EDGAR filings for this company.
PDF Report 0000872589_2026_Regeneron_Pharmaceuticals_INC.pdf
Logs
Graph
Absolute values for 0000872589, Regeneron Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 18,021,900,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,257,400,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 21,279,400,000 |
| 4 | LiabilitiesCurrent | 4,368,400,000 |
| 5 | LiabilitiesNoncurrent | 4,213,400,000 |
| 6 | remainder_Liabilities | 720,000,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,607,806,999 |
| 9 | ResearchAndDevelopmentExpense | 6,879,841,882 |
| 10 | remainder_Expenses | 2,806,617,018 |
| 11 | remainder_Revenues | 14,314,421,328 |
| 12 | remainder_NetIncome | 5,870,601,769 |
| 13 | remainder_ComprehensiveNetIncome | 81,381,260 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 40,558,700,000 |
| 1 | Liabilities | 9,301,800,000 |
| 2 | Expenses | 12,294,265,899 |
| 3 | Revenues | 14,314,421,328 |
| 4 | StockholdersEquity | 31,256,900,000 |
| 5 | NetIncome | 7,890,757,198 |
| 6 | ComprehensiveNetIncome | 7,931,447,828 |
| 7 | BaseVar | 41,210,585,128 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.05 |
| 9 | EconomicCapitalRatio | 3.72 |
Edgar->Model Mapping
Feature Distribution
Change over Time
